Related Experiment Videos
Patrizia Popoli1, Giovanni Giuliani2, Arturo Cavaliere3
1Centro Nazionale Ricerca e Valutazione Preclinica e Clinica dei Farmaci, Istituto Superiore di Sanità - Italy.
Global & Regional Health Technology Assessment
|June 21, 2024
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Closing the first wave of drug innovativeness in italy: final evidence from 2017 to 2025.
The European journal of health economics : HEPAC : health economics in prevention and care·2026
Assessment and Appraisal of Drug Innovativeness in Italy: Ultimate Evidence on Key Drivers and Consistency.
Journal of market access & health policy·2026
Paving the road for a successful EU HTA Reform implementation.
Global & regional health technology assessment·2025
Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past?
Journal of market access & health policy·2025
The Costs of Digital Health Interventions to Improve Immunization Data in Low- and Middle-Income Countries: Multicountry Mixed Methods Study.
Journal of medical Internet research·2025
Obesity in Italy: An Empirical Analysis of Healthcare Consumption, Quality of Life and Comorbidities.
Medicina (Kaunas, Lithuania)·2025
Integrating MCDA and economic evaluation into a rule-based framework for hospital-level health technology assessment.
Global & regional health technology assessment·2026
Burden of primary biliary cholangitis on the Italian National Health Service: retrospective analysis from an administrative database.
Global & regional health technology assessment·2026
Pharmacoeconomic analysis of switch to faricimab for neovascular age-related macular degeneration in real clinical practice.
Global & regional health technology assessment·2026
Impact of AIFA Note 100 on innovative antidiabetic prescribing eligibility in two Italian local health authorities: drug utilization and patient characteristics.
Global & regional health technology assessment·2026
Impact of Ministerial Decree 77/2022 from different stakeholders' perspectives: clinicians, pharmacists, patients, and industry.
Global & regional health technology assessment·2026
Procedural activity and dynamics of the new Italian Scientific and Economic Committee (CSE): a one-year observational analysis.
Global & regional health technology assessment·2026